Meylan, France

François Guillot

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: François Guillot. Retrieved from https://idiyas.com/inventor/franandccedilois-guillot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of François Guillot

Introduction

François Guillot is a notable inventor based in Meylan, France. He has made significant contributions to the field of immunoassays, particularly through his innovative methods that enhance the accuracy and efficiency of testing.

Latest Patents

Guillot holds a patent for a "Method for carrying out a homogeneous-immunoassay based on agglutination." This invention involves a homogeneous immunoassay utilizing an Fab'-biotin material and agglutinatable particles that carry streptavidin or avidin. The patent also details the Fab'-biotin, which is linked to a label compound capable of electrochemiluminescence, with the particles featuring magnetic properties due to the presence of avidin or streptavidin on their surface. He has 1 patent to his name.

Career Highlights

François Guillot is associated with Boehringer Mannheim GmbH, where he has been able to apply his expertise in immunoassays. His work has contributed to advancements in diagnostic testing, making it more reliable and efficient.

Collaborations

Guillot has collaborated with notable colleagues, including Arno Deger and Michael Berger. Their combined efforts have furthered research and development in the field of immunoassays.

Conclusion

François Guillot's innovative work in the field of immunoassays exemplifies the impact of dedicated inventors on medical diagnostics. His contributions continue to influence the industry and improve testing methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…